MBIO · Mustang Bio Inc
United States · RS rating 5 · As of 2026-10-14
| Price | 0.37 USD |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 8 / 7 / 7 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 3 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -14.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +77.8% |
| Market cap (USD) | $5.8M |